(Updated - June 2, 2026 7:37 AM EDT)

Wedbush analyst David Nierengarten upgraded Abivax (NASDAQ: ABVX) from Underperform to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades